A general practice study of timolol/hydrochlorothiazide/amiloride ('Moducren'), a new therapy for hypertension, and the doctor's influence on management

An open study was carried out in general practice to assess the efficacy and tolerance of a timolol (10 mg)/hydrochlorothiazide (25 mg)/amiloride (2.5 mg) preparation in 558 hypertensive patients previously receiving multi-dose antihypertensive therapy, and to determine whether the results were infl...

Description complète

Détails bibliographiques
Publié dans:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC). - 1995. - 3(1983), 5 vom: 01., Seite 294-9
Auteur principal: Parry, E E (Auteur)
Autres auteurs: Arr, S, Tait, D
Format: Article
Langue:English
Publié: 1983
Accès à la collection:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
Sujets:Clinical Trial Journal Article Randomized Controlled Trial Drug Combinations Propanolamines Pyrazines Hydrochlorothiazide 0J48LPH2TH moducrin 73788-01-9 plus... Amiloride 7DZO8EB0Z3 Timolol 817W3C6175